Markets.com Logo

BIVI

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    1.5445$
  • Previous Close
    1.5124$
  • 52 Week Change
    43.34$
  • Day Range
    0.03$
  • 52 Week High/Low
    1.46$ - 44.8$
  • Dividend Per Share
    --
  • Market cap
    11 664 K$
  • EPS
    -1.88
  • Beta
    1.068
  • Volume
    --

About

BIVI.US represents BioVie Inc., a biopharmaceutical company focused on developing innovative drug therapies for neurodegenerative and neurological disorders. The company's lead product candidate, NE3107, is an oral small molecule being developed for the treatment of Alzheimer's disease and other neuroinflammatory conditions. BioVie is conducting clinical trials to evaluate the safety and efficacy of NE3107 and other potential therapies.
Gold prices analysis: Gold prices in the United Arab Emirates climb as Middle East conflict continues

Gold prices analysis: Gold prices in the United Arab Emirates climb as Middle East conflict continues

Ghko B|--
Oil markets analysis: Oil prices spike as middle east tensions disrupt global supply

Oil markets analysis: Oil prices spike as middle east tensions disrupt global supply

Ghko B|--
Artificial Intelligence (AI) stock forecast: CoreWeave (CRWV) stock crashes 20%, what’s next?

Artificial Intelligence (AI) stock forecast: CoreWeave (CRWV) stock crashes 20%, what’s next?

Ghko B|--
Vanguard S&P 500 ETF forecast 2026: Will VOO stock continue to go up?

Vanguard S&P 500 ETF forecast 2026: Will VOO stock continue to go up?

Ghko B|--
Oil price forecast 2026: Oil prices surge, will the Iran conflict drive oil prices higher?

Oil price forecast 2026: Oil prices surge, will the Iran conflict drive oil prices higher?

Ghko B|--
European stocks analysis: What's going on in Europe stock market?

European stocks analysis: What's going on in Europe stock market?

Frances Wang|--
Market Sentiment Analysis: The Impact of S&P 500 on UAE Investor Confidence

Market Sentiment Analysis: The Impact of S&P 500 on UAE Investor Confidence

Ghko B|--

Factors

Please include at least 3 factors. Clinical Trial Results: Positive outcomes in clinical trials for BIVI.US's drug candidates significantly boost investor confidence, driving up stock prices. Conversely, negative or inconclusive results can lead to a sharp decline.

Regulatory Approvals: Receipt of regulatory approvals from bodies like the FDA for BIVI.US's products is a major catalyst, signaling market access and potential revenue generation. Delays or rejections negatively impact stock value.

Market Sentiment: Overall investor sentiment towards the biotechnology sector, influenced by economic conditions, geopolitical events, and broader market trends, affects BIVI.US. A positive market environment usually benefits the stock, while negative sentiment can pressure it downwards.

People Also Watch

Latest news

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee|--
Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Noah Lee|--
Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Liam James|--

Latest Education Articles

Learn to trade: buy/sell stock CFDs online, how to invest in stocks in UAE?

Learn to trade: buy/sell stock CFDs online, how to invest in stocks in UAE?

Ghko B|--
CFD Trading & Markets: How do I register for CFD trading in the United Arab Emirates (UAE)?

CFD Trading & Markets: How do I register for CFD trading in the United Arab Emirates (UAE)?

Ghko B|--
CFD Trading & Markets: How to start CFD trading in United Arab Emirates?

CFD Trading & Markets: How to start CFD trading in United Arab Emirates?

Ghko B|--